Irbesartan Tablet
Product Images NDC 70518-1690

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Irbesartan (NDC 70518-1690). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

This is a prescription drug called Irbesartan which is available in the form of tablets with a strength of 150 mg. The package contains 90 tablets. The medication must only be used as per the doctor's prescription. The direction for use is mentioned in the package insert. The drug must be stored between 15-30°C (59-86°F) and should be kept away from children. The lot number, expiry date, and source NDC are mentioned on the package. The medication is repackaged by a company called RemedyRepack Inc. located in Indiana, PA 15701.*

FDA Label Image

Structure (Spl Image1 Structure)

FDA Label Image

Figure 1 (Spl Image2 Figure1)

FDA Label Image

Figure 2 (Spl Image3 Figure2)

FDA Label Image

Figure 3 (Spl Image4 Figure3)

This is a clinical study related to two medications for hypertension: Besartan and Amlodpine. There was a comparison between Besartan and a Placebo, and between Ibesartan and Amlodpine. The study tracked follow-up for a certain period of time. The rest of the text is not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.